InhaleRx Limited (AU:IRX) has released an update.
InhaleRx Limited, an Australian healthcare company, has converted $413,307.26 of their Convertible Loan Facility into 17,969,880 ordinary shares. This move, made without raising new funds, effectively discharges the principal and accrued interest of the loan, showcasing the ongoing support from their investors. InhaleRx is focused on developing inhaled drug-device products for pain management and mental health, aiming for significant market opportunities.
For further insights into AU:IRX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
